Clinical trials
Completed Pulmonary Fibrosis trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2010 | 2 |
| 2011 | 2 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 2 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 13 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Boehringer Ingelheim | 4 |
| Guangdong Hengrui Pharmaceutical Co., Ltd | 2 |
| Guangzhou JOYO Pharma Co., Ltd | 2 |
| Beijing Chao Yang Hospital | 1 |
| Bristol-Myers Squibb | 1 |
| Creative Biosciences (Guangzhou) Co., Ltd. | 1 |
| InSilico Medicine Hong Kong Limited | 1 |
| North Sichuan Medical College | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pulmonary Fibrosis | 13 |
| Idiopathic Pulmonary Fibrosis | 4 |
| Lung Diseases | 3 |
| Respiratory Tract Diseases | 3 |
| Bronchitis | 2 |
| Idiopathic Interstitial Pneumonias | 2 |
| Lung Diseases, Interstitial | 2 |
| Lung Neoplasms | 2 |
| Pneumonia | 2 |
| Tuberculosis | 2 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.